vs
Side-by-side financial comparison of RHYTHM PHARMACEUTICALS, INC. (RYTM) and Vitesse Energy, Inc. (VTS). Click either name above to swap in a different company.
Vitesse Energy, Inc. is the larger business by last-quarter revenue ($58.6M vs $57.3M, roughly 1.0× RHYTHM PHARMACEUTICALS, INC.). Vitesse Energy, Inc. runs the higher net margin — -1.3% vs -83.0%, a 81.7% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 4.8%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -2.1%).
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
Vitesse Energy, Inc. is a U.S.-headquartered independent energy company focused on exploration, development, and production of oil and natural gas assets. It operates primarily in high-potential onshore basins including North Dakota's Williston Basin, serving domestic and global upstream energy market demand.
RYTM vs VTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.3M | $58.6M |
| Net Profit | $-47.5M | $-739.0K |
| Gross Margin | 91.6% | — |
| Operating Margin | -82.2% | -12.0% |
| Net Margin | -83.0% | -1.3% |
| Revenue YoY | 36.9% | 4.8% |
| Net Profit YoY | -9.6% | 85.6% |
| EPS (diluted) | $-0.73 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $57.3M | $58.6M | ||
| Q3 25 | $51.3M | $67.4M | ||
| Q2 25 | $48.5M | $81.8M | ||
| Q1 25 | $32.7M | $66.2M | ||
| Q4 24 | $41.8M | $55.9M | ||
| Q3 24 | $33.3M | $58.3M | ||
| Q2 24 | $29.1M | $66.6M | ||
| Q1 24 | $26.0M | $61.2M |
| Q4 25 | $-47.5M | $-739.0K | ||
| Q3 25 | $-52.9M | $-1.3M | ||
| Q2 25 | $-46.6M | $24.7M | ||
| Q1 25 | $-49.5M | $2.7M | ||
| Q4 24 | $-43.3M | $-5.1M | ||
| Q3 24 | $-43.6M | $17.4M | ||
| Q2 24 | $-32.3M | $10.9M | ||
| Q1 24 | $-141.4M | $-2.2M |
| Q4 25 | 91.6% | — | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 88.6% | — | ||
| Q1 25 | 88.8% | — | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 88.5% | — | ||
| Q2 24 | 89.9% | — | ||
| Q1 24 | 89.2% | — |
| Q4 25 | -82.2% | -12.0% | ||
| Q3 25 | -102.6% | 0.2% | ||
| Q2 25 | -93.4% | 22.8% | ||
| Q1 25 | -143.7% | 8.1% | ||
| Q4 24 | -98.6% | 3.7% | ||
| Q3 24 | -132.0% | 15.4% | ||
| Q2 24 | -139.2% | 25.2% | ||
| Q1 24 | -538.7% | 21.4% |
| Q4 25 | -83.0% | -1.3% | ||
| Q3 25 | -103.1% | -1.9% | ||
| Q2 25 | -96.1% | 30.2% | ||
| Q1 25 | -151.4% | 4.0% | ||
| Q4 24 | -103.6% | -9.2% | ||
| Q3 24 | -131.2% | 29.9% | ||
| Q2 24 | -110.9% | 16.4% | ||
| Q1 24 | -544.4% | -3.6% |
| Q4 25 | $-0.73 | $-0.01 | ||
| Q3 25 | $-0.82 | $-0.03 | ||
| Q2 25 | $-0.75 | $0.60 | ||
| Q1 25 | $-0.81 | $0.08 | ||
| Q4 24 | $-0.71 | $-0.15 | ||
| Q3 24 | $-0.73 | $0.53 | ||
| Q2 24 | $-0.55 | $0.33 | ||
| Q1 24 | $-2.35 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $388.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $139.1M | $629.3M |
| Total Assets | $480.2M | $893.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $388.9M | — | ||
| Q3 25 | $416.1M | — | ||
| Q2 25 | $291.0M | — | ||
| Q1 25 | $314.5M | $4.5M | ||
| Q4 24 | $320.6M | $3.0M | ||
| Q3 24 | $298.4M | — | ||
| Q2 24 | $319.1M | — | ||
| Q1 24 | $201.2M | — |
| Q4 25 | $139.1M | $629.3M | ||
| Q3 25 | $148.8M | $650.3M | ||
| Q2 25 | $-11.9M | $671.9M | ||
| Q1 25 | $18.9M | $667.7M | ||
| Q4 24 | $21.7M | $500.3M | ||
| Q3 24 | $11.2M | $520.4M | ||
| Q2 24 | $39.3M | $518.5M | ||
| Q1 24 | $61.6M | $522.7M |
| Q4 25 | $480.2M | $893.4M | ||
| Q3 25 | $506.9M | $932.9M | ||
| Q2 25 | $372.7M | $951.5M | ||
| Q1 25 | $386.7M | $975.2M | ||
| Q4 24 | $392.3M | $810.9M | ||
| Q3 24 | $363.6M | $791.2M | ||
| Q2 24 | $381.8M | $778.4M | ||
| Q1 24 | $258.7M | $749.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.4M | $37.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.4M | $37.4M | ||
| Q3 25 | $-26.6M | $49.4M | ||
| Q2 25 | $-23.3M | $66.0M | ||
| Q1 25 | $-40.4M | $17.5M | ||
| Q4 24 | $-18.8M | $34.7M | ||
| Q3 24 | $-25.2M | $45.7M | ||
| Q2 24 | $-29.1M | $35.2M | ||
| Q1 24 | $-40.7M | $39.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.68× | ||
| Q1 25 | — | 6.56× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.62× | ||
| Q2 24 | — | 3.22× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RYTM
Segment breakdown not available.
VTS
| Oil Reserves | $54.5M | 93% |
| Natural Gas Reserves | $4.2M | 7% |
